-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials
-
accounts Payable
12,527,000,000
-
cash Change
17,720,000,000
-
cash Flow
7,438,000,000
-
cash Flow Financing
2,726,000,000
-
changes In Inventories
18,263,000,000
-
changes In Receivables
28,331,000,000
-
common Stock
1,283,000,000
-
cost Of Revenue
51,455,000,000
-
currency
USD
-
current Assets
68,706,000,000
-
current Cash
17,720,000,000
-
current Debt
1,778,000,000
-
current Long Term Debt
1,778,000,000
-
depreciation
1,001,000,000
-
ebit
3,795,000,000
-
ebitda
4,796,000,000
-
filing Type
10-Q
-
fiscal Date
2023-03-31
-
fiscal Quarter
1
-
fiscal Year
2023
-
goodwill
84,057,000,000
-
gross Profit
33,823,000,000
-
income Tax
737,000,000
-
intangible Assets
26,368,000,000
-
interest Income
589,000,000
-
inventory
18,263,000,000
-
long Term Debt
56,450,000,000
-
long Term Investments
170,624,000,000
-
minority Interest
198,000,000
-
net Borrowings
36,741,000,000
-
net Income
2,136,000,000
-
net Income Basic
2,136,000,000
-
net Tangible Assets
--39,043,000,000
-
operating Expense
81,483,000,000
-
operating Income
3,795,000,000
-
operating Revenue
85,278,000,000
-
other Assets
8,055,000,000
-
other Current Assets
3,767,000,000
-
other Current Liabilities
60,749,000,000
-
other Income Expense Net
0
-
other Liabilities
15,580,000,000
-
pretax Income
2,879,000,000
-
property Plant Equipment
12,872,000,000
-
receivables
28,331,000,000
-
report Date
2023-05-03
-
research And Development
0
-
retained Earnings
57,753,000,000
-
revenue
85,278,000,000
-
selling General And Admin
0
-
shareholder Equity
71,382,000,000
-
short Term Debt
1,778,000,000
-
short Term Investments
3,767,000,000
-
symbol
CVS
-
total Assets
239,330,000,000
-
total Cash
17,720,000,000
-
total Debt
58,228,000,000
-
total Investing Cash Flows
--8,514,000,000
-
total Liabilities
167,948,000,000
-
total Revenue
85,278,000,000
-
treasury Stock
--33,802,000,000
-
id
FINANCIALS
-
key
CVS
-
subkey
quarterly
-
date
2023-03-31
-
updated
2023-05-11
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
CVS stock fundamentals - financials